Peer-Reviewed Publication

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study – September 23, 2021

View

Podcasts

DDW Podcast: The Bamlanivimab story – how it reached the clinic in eight months

Listen

Peer-Reviewed Publication

Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern – September 14, 2021

View

Webinar

Effectively Screen Biotherapeutic Targets Using Carterra’s Powerful Software Suite

View

Peer-Reviewed Publication

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants – September 9, 2021

View

Peer-Reviewed Publication

Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential

View

Application Note

NiHC200M Biosensor Kinetic Assays on the Carterra® LSA®

View

Application Note

Rapid Kinetic and Antagonistic Profile Screening of Hybridoma Supernatants, a COVID-19 Case Study

View

Application Note

High Sensitivity Assay Development on the LSA®

View

Peer-Reviewed Publication

Presence and Strength of Binding of IgM, IgG and IgA Antibodies Against SARS-CoV-2 During COVID-19 Infection – July 1, 2021

View

Webinar

Picking the Best Antibody Therapeutic Candidates to Develop the Most Effective COVID-19 Therapeutic Cocktail

View

Peer-Reviewed Publication

High throughput surface plasmon resonance imaging method for clinical detection of presence and strength of binding of IgM, IgG and IgA antibodies against SARS-CoV-2 during COVID-19 infection

View

Webinar

Accelerated High-Throughput and High-Content Antibody Discovery Targeting SARS-CoV-2 Spike Protein

View

Webinar

Accelerating Drug Discovery at a Pandemic Pace

View